The company, which has become Europe’s most valuable start-up, is preparing to launch its UK bank this year. Revolut already ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new study found that some rattlesnakes are producing simpler venoms containing fewer and more focused toxin families than complex venoms -- a surprising discovery that challenges long-held ideas ...

The message that Ainnova’s CEO, Vinicio Vargas, continues to convey to audiences around the world is that this accessible, fast, and scalable solution is designed to support early intervention and ...

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut transcatheter aortic valve replacement (TAVR) system in low-risk aortic ...

The Evolut FX TAVR [Image courtesy of Medtronic] Chicago was the site for the latest edition of the American College of Cardiology (ACC) Scientific Sessions. There, a number of the biggest names ...

On Sunday, Medtronic published five-year data from a low-risk clinical trial of its Evolut transcatheter aortic valve replacement (TAVR) system. In the trial, TAVR, which assists patients ...

GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the ...

Peking University, March 31, 2025: A simulation on the origin and evolution of North Atlantic Oscillation (NAO) has been conducted by a PKU research team led by Nie Ji, Associate Professor of ...

Medtronic (MDT) announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut transcatheter aortic valve replacement, TAVR, system ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years ...